Further mechanistic experimental studies have indicated that circGLIS3 may competitively bind miR-1273f and promote SKP1 expression, thereby promoting cyclin D1 overexpression, ultimately promoting the proliferation of bladder cancer cells. The gene discussed is SKP1; the disease is urinary bladder carcinoma.